ACTRN12616000029493
Recruiting
Phase 1
Safety and feasibility trial of motor cortex stimulation via Implanted Pulse Generators (IPG) to modulate interhemispheric inhibition in order to augment rehabilitation post stroke.
Ministry of Business, Innovation and Employment0 sites20 target enrollmentJanuary 18, 2016
Overview
- Phase
- Phase 1
- Intervention
- Not specified
- Conditions
- Not specified
- Sponsor
- Ministry of Business, Innovation and Employment
- Enrollment
- 20
- Status
- Recruiting
- Last Updated
- 6 years ago
Overview
Brief Summary
No summary available.
Investigators
Eligibility Criteria
Inclusion Criteria
- •1\. Aged at least 18 years on the day of consent
- •2\. capable of understanding and signing an informed consent form
- •3\. have a cortical or subcortical stroke at least 4 months earlier, screened by prior CT/MRI and verified by study MRI
- •4\. been assessed by physiotherapy and deemed suitable (UEFM 20 to 50\-moderate to mild upper limb function; Motor Assessment Scale: 2/6 on the Upper Arm Function scale; likely to be able to participate in 80% or more of the 12 weeks of daily physiotherapy post\-surgery sessions)
- •5\. suitable and fit for surgery
Exclusion Criteria
- •1\. history of epileptic seizures
- •2\. participants with pacemakers/defibrillators
- •3\. participants who have contraindications for MRI and TMS
- •4\. female participants who are or intend to become pregnant
- •5\. participants who, in the opinion of the investigators, do not understand the information and procedures of the study, or would not be compliant with them (in particular the study restrictions and risks involved)
- •6\. participants who have pain, significant musculotendinous or bony restrictions of the affected upper limb, chronic disease (other than stroke) that will independently cause significant disability or weakness of the affected upper limb
- •7\. any participant for whom the investigators believe, for any reason, that participation would not be an acceptable risk
- •8\. patients in whom any anticoagulation treatment cannot be transiently stopped in the preoperative period, analogous to what is done in the routine brain surgery (5 to 10 days stop before the surgery, and 2 days postoperatively, depending on the medication use)
Outcomes
Primary Outcomes
Not specified
Similar Trials
Recruiting
Not Applicable
External brain stimulation to augment rehabilitation therapy in individuals post strokeStrokeStroke - HaemorrhagicStroke - IschaemicACTRN12619000692134Professor John Reynolds24
Terminated
Phase 3
CONCEPT: Crossover Efficacy Pain Trial in Motor Cortex Stimulation for Intractable Neuropathic PainPain, IntractableFacial PainNCT00122915MedtronicNeuro104
Unknown
Phase 1
Safety and Efficacy of Motor Cortex Stimulation in the Treatment of Advanced Parkinson DiseaseParkinson DiseaseNCT00159172Assistance Publique - Hôpitaux de Paris10
Terminated
Phase 1
Assessment of the Safety and Effectiveness of Cortical Stimulation in Subjects With Major Depressive DisorderDepressionDepressive DisorderNCT00380042Northstar Neuroscience12
Terminated
Phase 1
Motor Cortex Stimulation for the Treatment of Chronic Facial, Upper Extremity, and Throat Pain.Trigeminal Neuralgia (Burchiel Type I)Trigeminal Neuralgia (Burchiel Type II)Trigeminal Neuropathic PainTrigeminal Deafferentation PainComplex Regional Pain Syndrome (Types I and II, Involving the Upper Extremity)Glossopharyngeal NeuralgiaUpper Extremity Pain Due to Deafferentation of the Cervical SpineCentral Pain SyndromesNCT02321566Johns Hopkins University1